Updated Jul 16, 2026
RUBIN PAUL D is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $1.15M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-03 | BIOA | BioAge Labs, Inc. | S — Open-market sale [10b5-1] | 8.8K | $17.81 | $157K |
| 2026-04-03 | BIOA | BioAge Labs, Inc. | M — Option exercise [10b5-1] | 3.4K | $6.57 | $22K |
| 2026-04-03 | BIOA | BioAge Labs, Inc. | M — Option exercise [10b5-1] | 5.4K | $4.11 | $22K |
| 2026-03-03 | BIOA | BioAge Labs, Inc. | S — Open-market sale [10b5-1] | 7.4K | $20.30 | $151K |
| 2026-03-03 | BIOA | BioAge Labs, Inc. | M — Option exercise [10b5-1] | 2.0K | $6.57 | $13K |
| 2026-03-03 | BIOA | BioAge Labs, Inc. | M — Option exercise [10b5-1] | 5.4K | $4.11 | $22K |
| 2026-02-03 | BIOA | BioAge Labs, Inc. | S — Open-market sale [10b5-1] | 7.4K | $18.75 | $139K |
| 2026-02-03 | BIOA | BioAge Labs, Inc. | M — Option exercise [10b5-1] | 2.0K | $6.57 | $13K |
| 2026-02-03 | BIOA | BioAge Labs, Inc. | M — Option exercise [10b5-1] | 5.4K | $4.11 | $22K |
| 2025-12-05 | BIOA | BioAge Labs, Inc. | S — Open-market sale [10b5-1] | 68.9K | $10.19 | $702K |
| 2025-12-05 | BIOA | BioAge Labs, Inc. | M — Option exercise [10b5-1] | 68.9K | $4.11 | $283K |
RUBIN PAUL D is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($1.15M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live RUBIN PAUL D profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.